Condition 1: Angina pectoris. Condition 2: Acute myocardial infarction. Condition 3: Subsequent myocardial infarction. Condition 4: Certain current complications following acute MI. Condition 5: Other acute ischemic heart diseases. Condition 6: Chronic ischaemic heart disease. Condition 7: Cerebral infarction. Angina pectoris ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Certain cur
Conditions
Interventions
Intervention 1: Intervention group: The family members in the intervention group will receive a comprehensive package of interventions facilitated by physicians. Interventions briefly include: 1) scre
limiting fat intake as low as they can
limiting the average daily salt intake to less than a quarter of a tablespoon
reducing daily sugar consumption to less than two tablespoons
maintaining a healthy weight through calorie reduction, enhancing fiber and protein intake by consumption of whole grain products and sprouted legumes, lowering glycemic load by substituting refined w
reducing stress and don’t use tobacco or alcohol.
Sponsors
Karaj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Family members aged 18 and older of patients diagnosed with cardiovascular disease, including fathers, mothers, siblings, spouses, and children
Exclusion criteria
Exclusion criteria: Individuals with a documented history of cardiovascular disease or stroke
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The study will assess the following health metrics: 1- Anthropometric indicators: Body Mass Index (BMI) and waist circumference. 2- Blood lipid indicators: triglycerides, LDL cholesterol, and HDL cholesterol. 3- Glycemic index. 4- Percentage of individuals with high blood pressure. 5- Percentage of individuals with diabetes. Timepoint: The outcomes will be measured before the study begins and again after six months. Method of measurement: Anthropometric indices will be assessed through clinical examinations, blood pressure will be measured using a sphygmomanometer, and lipid indices will be evaluated through blood sample analysis. | — |
Secondary
| Measure | Time frame |
|---|---|
| Predicting the 10-year risk of cardiovascular diseases. Timepoint: The outcomes will be measured before the study begins and again after six months. Method of measurement: The risk will be assessed using the updated Framingham Risk Assessment instrument tailored for the Iranian population. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mostafa Qorbani
Karaj University of Medical Sciences
Outcome results
None listed